Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Auryxia. Always confirm against the full prescribing information.
72 interactions
Alendronic acid
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Alendronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Asenapine
Asenapine can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Carbidopa
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Carbidopa resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Cefdinir
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Cefdinir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Cimetidine
Cimetidine can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Ciprofloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Tetraferric tricitrate decahydrate.
Level 1 evidence
Delafloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Demeclocycline
Demeclocycline can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Dolutegravir
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Dolutegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Doxepin
Doxepin can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Doxycycline
Doxycycline can cause a decrease in the absorption of Tetraferric tricitrate decahydrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Enter your NPI to unlock 2 major interactions for Auryxia
Auryxia (Ferric Citrate) has 72 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Auryxia (Ferric Citrate) has 2 major, 42 moderate, and 28 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Auryxia. Always confirm against the full prescribing information.